Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Payables (2020 - 2025)

Stemtech (STEK) has disclosed Payables for 6 consecutive years, with $7.7 million as the latest value for Q3 2025.

  • Quarterly Payables changed N/A to $7.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $7.7 million through Sep 2025, changed N/A year-over-year, with the annual reading at $6.6 million for FY2024, 64.64% up from the prior year.
  • Payables hit $7.7 million in Q3 2025 for Stemtech, up from $7.6 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $7.7 million in Q3 2025 to a low of $2.8 million in Q3 2022.
  • Historically, Payables has averaged $5.2 million across 5 years, with a median of $5.0 million in 2021.
  • Biggest five-year swings in Payables: dropped 22.48% in 2023 and later soared 64.64% in 2024.
  • Year by year, Payables stood at $4.5 million in 2021, then dropped by 14.68% to $3.8 million in 2022, then rose by 3.76% to $4.0 million in 2023, then skyrocketed by 64.64% to $6.6 million in 2024, then increased by 17.35% to $7.7 million in 2025.
  • Business Quant data shows Payables for STEK at $7.7 million in Q3 2025, $7.6 million in Q2 2025, and $7.3 million in Q1 2025.